HealthStream (NASDAQ:HSTM) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of HealthStream (NASDAQ:HSTM) from a hold rating to a buy rating in a research report report published on Saturday,Wall Street Zen reports.

A number of other equities analysts have also weighed in on the company. Freedom Capital raised HealthStream to a “hold” rating in a research note on Tuesday, October 13th. Canaccord Genuity Group increased their target price on HealthStream from $24.00 to $27.00 and gave the stock a “hold” rating in a research report on Tuesday, July 21st. Weiss Ratings raised HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Finally, Citigroup reissued a “market perform” rating on shares of HealthStream in a report on Tuesday, October 27th. One equities research analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $27.00.

HealthStream Stock Performance

Shares of HealthStream stock opened at $34.58 on Friday. The company has a market capitalization of $1.01 billion, a P/E ratio of 48.03, a P/E/G ratio of 3.90 and a beta of 0.42. The company has a fifty day moving average of $31.05 and a 200 day moving average of $25.65. HealthStream has a fifty-two week low of $19.50 and a fifty-two week high of $35.60.

HealthStream (NASDAQ:HSTM) last issued its quarterly earnings results on Monday, November 2nd. The technology company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.02. The business had revenue of $83.31 million during the quarter, compared to analyst estimates of $82.24 million. HealthStream had a return on equity of 6.81% and a net margin of 6.60%. Analysts forecast that HealthStream will post 0.72 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Robert A. Frist, Jr. sold 144,068 shares of HealthStream stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $29.50, for a total value of $4,250,006.00. Following the sale, the chief executive officer directly owned 3,907,038 shares of the company’s stock, valued at approximately $115,257,621. The trade was a 3.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Linda Rebrovick sold 12,000 shares of the business’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $35.00, for a total value of $420,000.00. Following the completion of the sale, the director owned 39,329 shares in the company, valued at $1,376,515. This represents a 23.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 20.40% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On HealthStream

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in HealthStream during the 2nd quarter valued at approximately $111,184,000. Dimensional Fund Advisors LP raised its holdings in shares of HealthStream by 6.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock worth $30,156,000 after acquiring an additional 87,177 shares in the last quarter. Copeland Capital Management LLC raised its holdings in shares of HealthStream by 43.8% during the 1st quarter. Copeland Capital Management LLC now owns 1,276,739 shares of the technology company’s stock worth $26,441,000 after acquiring an additional 389,186 shares in the last quarter. Renaissance Technologies LLC boosted its position in shares of HealthStream by 0.5% during the 1st quarter. Renaissance Technologies LLC now owns 477,848 shares of the technology company’s stock valued at $9,896,000 after acquiring an additional 2,380 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its position in shares of HealthStream by 21.1% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 377,945 shares of the technology company’s stock valued at $7,827,000 after acquiring an additional 65,806 shares during the last quarter. 69.58% of the stock is owned by institutional investors.

About HealthStream

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.

The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.